Annual Working Capital
$43.89 M
+$32.92 M+300.06%
December 31, 2023
Summary
- As of February 23, 2025, XLO annual working capital is $43.89 million, with the most recent change of +$32.92 million (+300.06%) on December 31, 2023.
- During the last 3 years, XLO annual working capital has risen by +$29.50 million (+205.05%).
- XLO annual working capital is now at all-time high.
Performance
XLO Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$25.29 M
-$14.08 M-35.77%
September 30, 2024
Summary
- As of February 23, 2025, XLO quarterly working capital is $25.29 million, with the most recent change of -$14.08 million (-35.77%) on September 30, 2024.
- Over the past year, XLO quarterly working capital has dropped by -$6.88 million (-21.40%).
- XLO quarterly working capital is now -86.67% below its all-time high of $189.74 million, reached on December 31, 2021.
Performance
XLO Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
XLO Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +300.1% | -21.4% |
| 3 y3 years | +205.1% | -21.4% |
| 5 y5 years | +4860.3% | -21.4% |
XLO Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +314.5% | -86.7% | at low |
| 5 y | 5-year | at high | +1062.3% | -86.7% | +1715.8% |
| alltime | all time | at high | +4860.3% | -86.7% | +1715.8% |
Xilio Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $25.29 M(-35.8%) |
| Jun 2024 | - | $39.37 M(+4.7%) |
| Mar 2024 | - | $37.60 M(+16.9%) |
| Dec 2023 | $43.89 M(+300.1%) | $32.17 M(-32.3%) |
| Sep 2023 | - | $47.55 M(-23.5%) |
| Jun 2023 | - | $62.13 M(-23.1%) |
| Mar 2023 | - | $80.78 M(-21.9%) |
| Dec 2022 | $10.97 M | $103.38 M(-17.6%) |
| Sep 2022 | - | $125.47 M(-13.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $145.24 M(-14.0%) |
| Mar 2022 | - | $168.86 M(-11.0%) |
| Dec 2021 | $10.59 M(-26.4%) | $189.74 M(+104.7%) |
| Sep 2021 | - | $92.70 M(-10.2%) |
| Jun 2021 | - | $103.28 M(-6699.4%) |
| Dec 2020 | $14.39 M(+281.0%) | -$1.56 M |
| Dec 2019 | $3.78 M(+326.8%) | - |
| Dec 2018 | $884.80 K(-55.2%) | - |
| Dec 2017 | $1.97 M(-18.1%) | - |
| Dec 2016 | $2.41 M | - |
FAQ
- What is Xilio Therapeutics annual working capital?
- What is the all time high annual working capital for Xilio Therapeutics?
- What is Xilio Therapeutics annual working capital year-on-year change?
- What is Xilio Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Xilio Therapeutics?
- What is Xilio Therapeutics quarterly working capital year-on-year change?
What is Xilio Therapeutics annual working capital?
The current annual working capital of XLO is $43.89 M
What is the all time high annual working capital for Xilio Therapeutics?
Xilio Therapeutics all-time high annual working capital is $43.89 M
What is Xilio Therapeutics annual working capital year-on-year change?
Over the past year, XLO annual working capital has changed by +$32.92 M (+300.06%)
What is Xilio Therapeutics quarterly working capital?
The current quarterly working capital of XLO is $25.29 M
What is the all time high quarterly working capital for Xilio Therapeutics?
Xilio Therapeutics all-time high quarterly working capital is $189.74 M
What is Xilio Therapeutics quarterly working capital year-on-year change?
Over the past year, XLO quarterly working capital has changed by -$6.88 M (-21.40%)